Wavena is a South Korean digital healthcare startup, founded in 2026 and based in Seoul, that develops AI capable of predicting more than 30 blood biomarkers from a 10-second ECG measurement without drawing blood. Its models are trained on a proprietary database of over 4 million ECG-blood matched clinical records from the Seoul National University Hospital network and reportedly achieve AUROC scores of 0.89-0.92 across nine biomarkers including hyperkalemia, kidney function, anemia and heart failure. The company is commercializing Wavena Medical, a clinical decision-support system for hemodialysis and critical care, alongside consumer, veterinary and non-invasive glucose monitoring products.
1
Round
1
Industry
4
Tags
Oct 8, 2026
Latest raise
Funding activity · 1 round
Oct 8, 2026
KRW 200M
Seed
Led by Seoul National University Technology Holdings
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
